Drug contracts with option to join
BARMER Beschaffung und Vergabe, WuppertalTED 640428-2026
value not stated3 lots
Tue 1 Aug12:00 in Berlin
642days
Public tenders in Germany
725 open tenders
CountryTenderValueClosesDays left
Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 of the German Social Code Book V (Open-House Model)
AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, EschbornTED 562187-2026
value not stated13 lots
Tue 1 Aug12:00 in Berlin
642days
Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance FAM OLIMEL (excluding electrolyte-free; 7, 6 %; KPG) + interchangeable FAM, ATC B05BA10 for the period 1.10.26-30.09.28
DAK-Gesundheit, HamburgTED 572069-2026
€11 lot, 2 years
Sat 5 Aug12:00 in Berlin
646days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Dapagliflozin, ATC A10BK01, for the period from 01.10.2026 to 30.09.2028
DAK-Gesundheit, HamburgTED 571195-2026
€11 lot, 2 years
Sat 5 Aug12:00 in Berlin
646days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance Rifaximin, ATC A07AA11, for the period 01.10.2026 - 30.09.2028
DAK-Gesundheit, HamburgTED 569831-2026
€11 lot, 2 years
Sat 5 Aug12:00 in Berlin
646days
Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Grass Pollen Extract (Timothy, Rye, etc.), ATC code V01AA02, for the period 01.10.2026 - 30.09.2028
DAK-Gesundheit, HamburgTED 571079-2026
€11 lot, 2 years
Sat 5 Aug12:00 in Berlin
646days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance FAM CERNEVIT (excluding KPG) and interchangeable FAM, ATC B05XC30, for the period 01.10.2026 - 30.09.2028
DAK-Gesundheit, HamburgTED 570900-2026
€11 lot, 2 years
Sat 5 Aug12:00 in Berlin
646days
Conclusion of a non-exclusive discount agreement under § 130a paragraph 8 of the German Social Security Code (SGB V) for the active substance Faricimab, ATC code S01LA09, for the period from 01.10.2026 to 30.09.2028
DAK-Gesundheit, HamburgTED 571028-2026
€11 lot, 2 years
Sat 5 Aug12:00 in Berlin
646days
Conclusion of a non-exclusive framework agreement for inspection audits, preliminary investigations and further construction technical investigations under the open-house procedure 2026 et seq.
Die Autobahn GmbH des Bundes - NL Rheinland, KrefeldTED 566712-2026
value not stated1 lot, 2 years
Mon 14 Aug23:59 in Berlin
655days
Conclusion of non-exclusive discount agreements under § 130a Abs. 8 SGB V (Open-House Model)
AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, EschbornTED 681348-2026
value not stated7 lots
Fri 1 Sep12:00 in Berlin
673days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Iron (parenteral preparations), ATC B03AC07 for the period 01.11.25-31.10.27 (including extension option 1x12 months)
DAK-Gesundheit, HamburgTED 606302-2025
€11 lot, 2 years
Tue 5 Sep12:00 in Berlin
677days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Iron (parenteral preparations), ATC B03AC02 for the period 01.11.25-31.10.27 (including extension option 1x12 months)
DAK-Gesundheit, HamburgTED 607974-2025
€11 lot, 2 years
Tue 5 Sep12:00 in Berlin
677days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Iron (parenteral preparations), ATC B03AC01 for the period 01.11.25-31.10.27 (including extension option 1x12 months)
DAK-Gesundheit, HamburgTED 603491-2025
€11 lot, 2 years
Tue 5 Sep12:00 in Berlin
677days
Wound care in accordance with § 31 SGB V
GWQ ServicePlus AG, DüsseldorfTED 716659-2025
value not stated1 lot, 2 years
Fri 8 Sep
680days
Open-House Contracts 2026-3
AOK Bremen/BremerhavenTED 619636-2026
value not stated37 lots
Sat 30 Sep23:59 in Berlin
702days
Conclusion of a non-exclusive rebate agreement pursuant to § 130a para. 8 SGB V for the active ingredient Glatiramer acetate (excluding pre-filled syringes), ATC L03AX13 for the period 01.12.2026 - 30.11.2028
DAK-Gesundheit, HamburgTED 713854-2026
€11 lot, 2 years
Thu 5 Oct12:00 in Berlin
707days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance Indacaterol + Glycopyrronium bromide, ATC R03AL04, for the period 01.12.2026 – 30.11.2028
DAK-Gesundheit, HamburgTED 712386-2026
€11 lot, 2 years
Thu 5 Oct12:00 in Berlin
707days
Conclusion of a non-exclusive rebate agreement pursuant to § 130a para. 8 SGB V for the active ingredient Botulinum toxin type A (excluding Onabotulinum), ATC M03AX21 for the period 01.12.2026 - 30.11.2028
DAK-Gesundheit, HamburgTED 712558-2026
€11 lot, 2 years
Thu 5 Oct12:00 in Berlin
707days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active ingredient Botulinum toxin type A (exclusively Abobotulinum), ATC M03AX21 for the period 01.12.2026 - 30.11.2028
DAK-Gesundheit, HamburgTED 714096-2026
€11 lot, 2 years
Thu 5 Oct12:00 in Berlin
707days
Conclusion of a non-exclusive rebate agreement pursuant to § 130a para. 8 SGB V for the active ingredient Ublituximab, ATC L04AG14 for the period 01.12.2026 - 30.11.2028
DAK-Gesundheit, HamburgTED 713501-2026
€11 lot, 2 years
Thu 5 Oct12:00 in Berlin
707days
SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.